Incanthera (AQSE:INC) Dividend Payout Ratio : 0.00 (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Incanthera Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Incanthera's Dividend Payout Ratio for the months ended in Sep. 2023 was 0.00.

The historical rank and industry rank for Incanthera's Dividend Payout Ratio or its related term are showing as below:

AQSE:INC's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.47
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-09-23), the Dividend Yield % of Incanthera is 0.00%.

Incanthera's Dividends per Share for the months ended in Sep. 2023 was £0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Incanthera Dividend Payout Ratio Historical Data

The historical data trend for Incanthera's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incanthera Dividend Payout Ratio Chart

Incanthera Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Dividend Payout Ratio

Incanthera Semi-Annual Data
	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Dividend Payout Ratio	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Incanthera's Dividend Payout Ratio

For the Biotechnology subindustry, Incanthera's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Incanthera's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Incanthera's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Incanthera's Dividend Payout Ratio falls into.

Incanthera Dividend Payout Ratio Calculation

Incanthera's Dividend Payout Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Mar. 2023 )	/	EPS without NRI (A: Mar. 2023 )
	=	0	/	-0.012
	=	N/A

Incanthera's Dividend Payout Ratio for the quarter that ended in Sep. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Sep. 2023 )	/	EPS without NRI (Q: Sep. 2023 )
	=	0	/	-0.008
	=	N/A

Incanthera (AQSE:INC) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Incanthera Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Incanthera's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Incanthera Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

76 King Street, Manchester, GBR, M2 4NH

Website

http://www.incanthera.com

Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising a new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.